According to Bustamante et al., based on a meta-analysis of 24 studies, it was found that IL-6 levels are associated with poor outcomes after stroke, but its predictive value was moderate, suggesting that IL-6′s practical application in clinical practice is unlikely [130]. The gene discussed is IL6; the disease is stroke disorder.